Synopsis
At 1.5 T
reciprocity principle based quantification strategies have been successfully used
to quantify brain metabolites. But these methods all rely on the assumption
that the magnitude of the RF transmission field B1+ and the reception field B1- are equal at all points in the
subject. This is not true at higher field strengths and for example differences
in the concentrations measured in the left and right hemisphere are observed
when these methods are directly applied at higher fields. Here a further development
is presented, proposing a correction for deviations of B1+ from B1- to allow
concentration measurements at 3T and even higher field strength without the
need of assumptions about concentrations of an internal reference. The obtained
metabolite concentrations in vivo in 31 healthy volunteers highly agree with
values estimated with internal water referencing, demonstrating the capabilities
of this new method, which might make concentration measurements in diseased tissue
more reliable. Introduction
When
the metabolite signal $$$S_{m}$$$ detected with MRS is compared to a reference
signal measured in a phantom with known concentrations and relaxation rates, it
is in principle possible to determine in vivo metabolite concentrations without
the need of assumptions about an internal reference. However, the changes in sensitivity,
i.e. the relation between the transversal magnetization and the detected
signal, between the in vivo and the phantom measurement need to be carefully considered.
At low field strength one can estimate the
magnitude of the $$$B_1^{+}$$$-field per unit current ($$$\mid{\hat{B_1^{+}}}\mid$$$)
obtained in the VOI and use it as measure of the local sensitivity
1.
This approach based on the reciprocity principle
2 uses the
assumption that the magnitude of the reception field ($$$\mid{\hat{B_1^{-}}}\mid$$$)
at a given position is equal to the magnitude of the transmission field ($$$\mid{\hat{B_1^{+}}}\mid$$$).
This is true at lower fields but has been demonstrated to be wrong at higher
field strengths
3,4. Hence at 3T $$$\mid{\hat{B_1^{+}}}\mid$$$
is not sufficient to estimate $$$\mid{\hat{B_1^{-}}}\mid$$$ at all positions in
the sample and can not be used solely to correct for sensitivity changes. In this work, we present a reciprocity
based reference method for quantitative MRS at 3T. We propose to use a volume
selective power optimization method
5 (volPO)
to determine automatically a measure of $$$\mid{\hat{B_1^{+}}}\mid$$$. This
shall not only simplify the measurement of the sensitivity changes but also
guarantee signal detection with an optimal flip angle. To account for the
deviations of $$$\mid{\hat{B_1^{+}}}\mid$$$ from $$$\mid{\hat{B_1^{-}}}\mid$$$
we introduce a correction factor C
p using reception sensitivity maps determined
from contrast minimized images
6. The proposed method is extensively
validated.
Methods
Experiments were
performed on a Philips Achieva 3T MRI scanner with a commercial T/R head coil. With
the mentioned volPO the scaling factor $$$\frac{1}{DS}$$$, which is
proportional to the RF pulse voltage needed to yield a given flip angle, is
determined prior to each spectroscopic scan and used as a measure of $$$\mid{\hat{B_1^{+}}}\mid$$$.
To investigate the stability of this measure the ratio of the water signal
$$$S_{H2O}$$$ and $$$\frac{1}{DS}$$$ was measured several times at the same
position in a water containing phantom.
The
ability to correct for the loading of the coil with $$$\frac{1}{DS}$$$ was
tested with a series of measurements in a small spherical water containing
phantom, while a plastic bottle containing a NaCl solution was stepwise inserted
into the coil.
In 31 healthy
volunteers always three PRESS-localized voxels (TE:30ms, TR:1800ms, 256
averages, 5ml) aranged in one plane were measured. One VOI was placed in the
longitudinal cerebral fissure just above the corpus callosum (position M)
containing mostly gray matter and the other two were shifted by 20 mm
respectively to the left (positon L) and to the right (position R) into
cerebral white matter. Metabolite concentrations using $$$\frac{1}{DS}$$$ were
calculated as follows:
$$c_{m}^{DS}=\frac{S_m}{S_{ref,c}}\frac{R_{ref,c}}{R_{m}}\frac{DS}{DS_{c}}\frac{C_{p,c}}{C_{p}}\frac{T}{T_{c}}c_{ref,c}\frac{l_{ref,c}}{l_{m}}\frac{1}{1-f_{CSF}}\qquad\text{[Eq.1]}$$
The subscript $$$c$$$ denotes quantities from the calibration measurement, were
the reference compound $$$ref$$$ with a known concentration $$$c_{ref}$$$ was
measured. $$$R$$$ are approximated relaxation attenuation factors [Table1], $$$T$$$
the temperature, $$$l$$$ the number of spins per molecule and $$$f_{CSF}$$$ the
volume fraction of the CSF. $$$C_p$$$ is the factor to correct deviations of $$$\mid{\hat{B_1^{+}}}\mid$$$
from $$$\mid{\hat{B_1^{-}}}\mid$$$. This factor is calculated in each VOI as
the ratio of the achieved $$$\mid{B_1^{+}}\mid$$$ taken from a $$$B_1$$$-map7 to the reception sensitivity
$$$Rx$$$ calculated using 2D reception sensitivity maps6. Both maps were scaled with the value
measured at the center of the coil.$$C_{p}=\frac{\mid{B_{1,VOI} ^{+}}\mid}{Rx_{VOI}}\qquad\text{[Eq.2]}$$Metabolite
concentrations obtained with Eq.1 are compared to values using tissue water as
reference8 (IWR). Total internal water concentrations obtained with Eq.1 (omitting
the last term) are compared with values predicted based on the individual voxel
composition:$$c^{seg}=55.126\cdot(f_{CSF}\cdot\alpha_{CSF}+f_{GM}\cdot\alpha_{GM}+f_{WM}\cdot\alpha_{WM})\qquad\text{[Eq.3]}$$
Results/Discussion
Changes in the loading of the coil
can be precisely corrected with
the proposed quantity $$$\frac{1}{DS}$$$ [Figure1]. During a time of 2.5 month $$$S_{H2O}$$$/$$$\frac{1}{DS}$$$
was measured 15 times in vitro with a CV of 0.78 % demonstrating a good
stability of the proposed method. The need and the effect of the correction factor $$$C_p$$$
in Eq.1 is demonstrated in vitro [Figure2] and in vivo [Figure3]. The
correction with $$$C_p$$$ allows to reproduce the $$$c^{seg}$$$ values at all three measured positions.
Metabolite concentrations obtained via Eq.1 and IWR highly agree as
demonstrated in [Figure4]. However so far only deviations of $$$\mid{\hat{B_1^{+}}}\mid$$$
from $$$\mid{\hat{B_1^{-}}}\mid$$$ along the RL and AP direction are
considered. The use of a 3D reception sensitivity map might further improve the
accordance of the obtained values.
In
conclusion, the proposed calibration strategy allows to obtain
reliable metabolite concentrations in vivo without the use of additional
hardware nor assumptions about an internal reference at 3T.
Acknowledgements
No acknowledgement found.References
[1] G
Helms. A precise and user-independent quantification technique for regional
comparison of single volume proton mr spectroscopy of the human brain. NMR in Biomedicine, 13(7):398–406, 2000.
[2] DI Hoult. The principle of
reciprocity in signal strength calculations—a mathematical guide. Concepts in Magnetic resonance,
12(4):173–187, 2000.
[3] CM Collins, QX Yang, JH Wang, X Zhang,
H Liu, S Michaeli, X-H Zhu, G Adriany, JT Vaughan,
P Anderson, et al. Different
excitation and reception distributions with a single-loop transmit-receive
surface coil near a head-sized spherical phantom at 300 mhz. Magnetic Resonance in Medicine,
47(5):1026–1028, 2002
[4] H
Watanabe. Investigation of the asymmetric distributions of rf transmission and
reception fields at high static field. Magnetic
Resonance in Medical Sciences, 11(2):129–135, 2012.
[5] J Wang, M Qiu, QX Yang, MB
Smith, and RT Constable. Measurement and correction of transmitter and receiver
induced nonuniformities in vivo. Magnetic
Resonance in Medicine, 53(2):408–417, 2005.
[6] MJ
Versluis, HE Kan, MA Buchem, and AG Webb. Improved signal to noise in proton spectroscopy of the human calf muscle
at 7 T using localized b1 calibration. Magnetic
Resonance in Medicine, 63(1):207–211, 2010.
[7] LI
Sacolick, F Wiesinger, I Hancu, and MW Vogel. B1 mapping by bloch-siegert
shift. Magnetic Resonance in Medicine,
63(5):1315–1322, 2010.
[8] R Kreis, T Ernst, and BD Ross. Absolute quantitation of water and
metabolites in the human brain. ii. metabolite concentrations. Journal of magnetic resonance, Series B,
102(1):9–19, 1993.
[9] F Träber, W Block, R Lamerichs, J Gieseke, and HH Schild. 1h metabolite relaxation times at
3.0 tesla: Measurements of t1 and t2 values in normal brain and determination
of regional differences in transverse relaxation. Journal of Magnetic Resonance Imaging, 19(5):537–545, 2004.
[10] W Zaaraoui,
L Fleysher, R Fleysher, S Liu, BJ Soher, and O Gonen. Human
brain-structure resolved t2 relaxation times of proton metabolites at 3 tesla. Magnetic Resonance in Medicine,
57(6):983–989, 2007.
[11] GJ
Stanisz, EE Odrobina, J Pun, M Escaravage, SJ Graham, MJ Bronskill, and RM
Henkelman. T1, t2 relaxation and magnetization transfer in tissue at 3t. Magnetic Resonance in Medicine,
54(3):507–512, 2005.
[12] L Chen, MA Bernstein, J Huston, and
S Fain. Measurements of
t1 relaxation times at 3.0 t: implications for clinical mra. In Proceedings of the 9th Annual Meeting of
ISMRM, Glasgow, Scotland, 2001.
[13] SK Piechnik,
J Evans, LH Bary, RG Wise, and P Jezzard. Functional changes in
csf volume estimated using measurement of water t2 relaxation. Magnetic Resonance in Medicine,
61(3):579–586, 2009